These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 477286)

  • 1. Anthracycline cardiotoxicity: recognition, management, and avoidance.
    Mason JW
    Compr Ther; 1979 Jul; 5(7):64-8. PubMed ID: 477286
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serial determination of anthracycline poisoning in children].
    Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H
    Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery from anthracycline cardiomyopathy--how can it be explained?
    Christiansen S
    J Heart Lung Transplant; 2009 Jul; 28(7):751. PubMed ID: 19560709
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monitoring cardiotoxicity during antineoplastic chemotherapy].
    Jurga L; Ponist J; Jonás P; Berc A; Misurová E
    Cesk Radiol; 1987 Jan; 41(1):28-37. PubMed ID: 3815581
    [No Abstract]   [Full Text] [Related]  

  • 5. Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction?
    Geffen DB; Liel-Cohen N
    Isr Med Assoc J; 2007 Sep; 9(9):690; author reply 690-1. PubMed ID: 17939640
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical spectrum of anthracycline antibiotic cardiotoxicity.
    Bristow MR; Billingham ME; Mason JW; Daniels JR
    Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.
    Octavia Y; Tocchetti CG; Gabrielson KL; Janssens S; Crijns HJ; Moens AL
    J Mol Cell Cardiol; 2012 Jun; 52(6):1213-25. PubMed ID: 22465037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].
    Göldel N; Autenrieth G; Werdan K; Knesewitsch P; Wilmanns W
    Z Kardiol; 1989 May; 78(5):320-7. PubMed ID: 2735093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse.
    Bertazzoli C; Bellini O; Magrini U; Tosana MG
    Cancer Treat Rep; 1979; 63(11-12):1877-83. PubMed ID: 526920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists: effects on cardiotoxicity caused by adriamycin. Preliminary trials].
    Polverino W; Basso A; Muto P; Genovese A; Perrone V; Apice G; Farace J
    Minerva Cardioangiol; 1983 Mar; 31(3):115-20. PubMed ID: 6856096
    [No Abstract]   [Full Text] [Related]  

  • 12. [The cardiotoxicity of anticancer agents].
    Wakasugi S
    Ryoikibetsu Shokogun Shirizu; 1996; (14):83-7. PubMed ID: 9047803
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity.
    Jones RL; Miles DW
    Lancet Oncol; 2005 Feb; 6(2):67. PubMed ID: 15683815
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
    Torti FM; Bristow MM; Lum BL; Carter SK; Howes AE; Aston DA; Brown BW; Hannigan JF; Meyers FJ; Mitchell EP
    Cancer Res; 1986 Jul; 46(7):3722-7. PubMed ID: 3458531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.
    De Angelis A; Piegari E; Cappetta D; Marino L; Filippelli A; Berrino L; Ferreira-Martins J; Zheng H; Hosoda T; Rota M; Urbanek K; Kajstura J; Leri A; Rossi F; Anversa P
    Circulation; 2010 Jan; 121(2):276-92. PubMed ID: 20038740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin (adriamycin) cardiomyopathy.
    Saltiel E; McGuire W
    West J Med; 1983 Sep; 139(3):332-41. PubMed ID: 6356608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiotoxicity of rubidomycin. Anatomo-clinical study of 1 case].
    Fontaine JL; Bonnet-Gajdos M; Mougenot B
    Arch Fr Pediatr; 1974; 31(7):697-704. PubMed ID: 4531839
    [No Abstract]   [Full Text] [Related]  

  • 18. Anthracycline cardiotoxicity.
    Ferrans VJ
    Adv Exp Med Biol; 1983; 161():519-32. PubMed ID: 6346820
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anthracyclin-cardiomyopathy (author's transl)].
    Kothe K; Ihle R; Romaniuk P; Stobbe H; Wagenknecht C
    Arch Geschwulstforsch; 1982; 52(2):141-54. PubMed ID: 6213212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin cardiomyopathy.
    Chatterjee K; Zhang J; Honbo N; Karliner JS
    Cardiology; 2010; 115(2):155-62. PubMed ID: 20016174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.